AZD7762 is a Chk1/2 inhibitor that is utilized as an enhancer of chemotherapy-induced apoptosis of cancer cells; however, its effects on neurons have not been widely studied [37] and the target for this compound in neurons needs to be identified. The gene discussed is CHEK1; the disease is cancer.